Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous malignancy, with highly variable outcomes among patients. Although classification and prognostic tools have been developed, standard therapy still fails in 30-40% of patients. Hence, identification of novel biomarkers is needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Santillan, Maria, Larrabeiti-Etxebarria, Ane, Arzuaga-Mendez, Javier, Lopez-Lopez, Elixabet, Garcia-Orad, Africa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978269/
https://www.ncbi.nlm.nih.gov/pubmed/29854319
http://dx.doi.org/10.18632/oncotarget.25230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978269/
https://www.ncbi.nlm.nih.gov/pubmed/29854319
http://dx.doi.org/10.18632/oncotarget.25230

Ejemplares similares